Literature DB >> 31822973

Assessment of microvessel perfusion of pituitary adenomas: a feasibility study using turbo spin-echo-based intravoxel incoherent motion imaging.

Kiyohisa Kamimura1, Masanori Nakajo1, Tomohide Yoneyama1, Yoshihiko Fukukura1, Shingo Fujio2, Yuko Goto3, Takashi Iwanaga4, Yuta Akamine5, Takashi Yoshiura6.   

Abstract

OBJECTIVES: To evaluate the feasibility of assessment of microvessel perfusion of pituitary adenomas with intravoxel incoherent motion (IVIM) imaging using single-shot turbo spin-echo-based diffusion-weighted imaging (SS-TSE-DWI).
METHODS: We examined 51 consecutive patients with pituitary adenomas (35 non-functioning and 16 functioning) and 32 patients with normal pituitary glands using SS-TSE-DWI IVIM. The diffusion coefficient (D), the perfusion fraction (f), and the pseudo-diffusion coefficient (D*) were calculated pixel-by-pixel for each adenoma and normal pituitary gland. We also obtained the pathological microvessel area (MVA) of each adenoma. The IVIM parameters in adenomas were compared with those in normal pituitary glands using the Mann-Whitney U test. The correlation between the MVA and IVIM f of adenomas was analyzed using Spearman's rank correlation coefficient.
RESULTS: The mean D (× 10-3 mm2/s) in adenomas was 0.723 ± 0.253, which was significantly lower than that in normal pituitary glands (0.862 ± 0.128; p < 0.0001). The mean f (%) in adenomas was 10.74 ± 4.51, which was significantly lower than that in normal pituitary glands (13.26 ± 4.32, p = 0.0251). No significant difference was found in the mean D*. We found a significant positive correlation between MVA and f in non-functioning adenomas (ρ = 0.634, p < 0.0001) as well as in all adenomas (ρ = 0.451, p = 0.0009).
CONCLUSIONS: Assessment of microvessel perfusion of pituitary adenomas based on SS-TSE-DWI IVIM is feasible. Compared to normal pituitary glands, pituitary adenomas were characterized by lower D and f. KEY POINTS: • Assessment of microvessel perfusion of pituitary adenomas based on SS-TSE-IVIM is feasible. • SS-TSE-IVIM helps with evaluation of the vascularity of pituitary lesions. • Pituitary adenomas were characterized by lower D and f than normal pituitary glands.

Entities:  

Keywords:  Intravoxel incoherent motion; Magnetic resonance imaging; Microvessels; Pituitary neoplasms

Mesh:

Year:  2019        PMID: 31822973     DOI: 10.1007/s00330-019-06443-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.

Authors:  N Kunii; T Abe; M Kawamo; D Tanioka; H Izumiyama; T Moritani
Journal:  Acta Neurochir (Wien)       Date:  2007-07-09       Impact factor: 2.216

2.  Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques.

Authors:  P A T Baltzer; D M Renz; K-H Herrmann; M Dietzel; I Krumbein; M Gajda; O Camara; J R Reichenbach; W A Kaiser
Journal:  Eur Radiol       Date:  2009-03-14       Impact factor: 5.315

3.  Evaluation of the antiangiogenic effects of octreotide on growth hormone-producing pituitary adenoma using arterial spin-labeling perfusion imaging.

Authors:  Naoto Sakai; Shuhei Yamashita; Yasuo Takehara; Harumi Sakahara; Satoshi Baba; Yutaka Oki; Goro Takahashi; Shinichiro Koizumi; Tetsuro Sameshima; Hiroki Namba
Journal:  Magn Reson Med Sci       Date:  2014-10-27       Impact factor: 2.471

4.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

5.  Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.

Authors:  Shuaitong Zhang; Guidong Song; Yali Zang; Jian Jia; Chao Wang; Chuzhong Li; Jie Tian; Di Dong; Yazhuo Zhang
Journal:  Eur Radiol       Date:  2018-03-23       Impact factor: 5.315

6.  Role of High-Resolution Dynamic Contrast-Enhanced MRI with Golden-Angle Radial Sparse Parallel Reconstruction to Identify the Normal Pituitary Gland in Patients with Macroadenomas.

Authors:  R Sen; C Sen; J Pack; K T Block; J G Golfinos; V Prabhu; F Boada; O Gonen; D Kondziolka; G Fatterpekar
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

7.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

Review 8.  The prevalence of pituitary adenomas: a systematic review.

Authors:  Shereen Ezzat; Sylvia L Asa; William T Couldwell; Charles E Barr; William E Dodge; Mary Lee Vance; Ian E McCutcheon
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

9.  Measurement of the perfusion fraction in brain tumors with intravoxel incoherent motion MR imaging: validation with histopathological vascular density in meningiomas.

Authors:  Osamu Togao; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Daichi Momosaka; Koji Yoshimoto; Daisuke Kuga; Masahiro Mizoguchi; Satoshi O Suzuki; Toru Iwaki; Marc Van Cauteren; Koji Iihara; Hiroshi Honda
Journal:  Br J Radiol       Date:  2018-02-16       Impact factor: 3.039

10.  Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.

Authors:  Chong Hyun Suh; Ho Sung Kim; Seung Soo Lee; Namkug Kim; Hee Mang Yoon; Choong-Gon Choi; Sang Joon Kim
Journal:  Radiology       Date:  2014-04-01       Impact factor: 11.105

View more
  1 in total

1.  Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study.

Authors:  Alberto Conficoni; Paola Feraco; Diego Mazzatenta; Matteo Zoli; Sofia Asioli; Corrado Zenesini; Viscardo Paolo Fabbri; Martino Cellerini; Antonella Bacci
Journal:  Br J Radiol       Date:  2020-07-06       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.